Paroxysmal Nocturnal Hemoglobinuria (PNH)

Dr. Austin Kulasekararaj is a hematologist at King’s College Hospital, London. He has trained and worked at King's since 2004, undertaking research in molecular pathogenesis of MDS and aplastic anemia. He specializes in bone marrow failures, myeloid malignancies, and allogeneic bone marrow transplantation. Dr. Kulasekararaj also leads the King's PNH Centre, which is one of two NHS England-commissioned highly specialized services for PNH.

As a physician caring for patients with acute leukemias and related disorders, I have a sustained focus on translational research in hematologic malignancies. Genomic sequencing technology revolutionized our understanding of cancer biology. My research focuses on exploring the dynamic changes of tumor immune microenvironment with clonal evolution of myeloid malignancies. Targeting inflammaging of bone marrow to impede clonal evolution is my ultimate professional goal and there by improve the survival rate for leukemia patients. My long-term goal is to develop potentially less toxic targeted

Dr. Elizabeth Bowhay-Carnes is a Texas native and passionate about serving the people of her home community. She earned her bachelors of science degree in biochemistry from the University of Texas at Austin, followed by work with the MD Anderson Cancer Center Umbilical Cord Blood Bank in Houston. She received her medical doctorate from UT Health San Antonio and completed her residency in internal medicine and fellowship in hematology and medical oncology at the UT Health Science Center. She joined UT Health San Antonio MD Anderson Cancer Center in 2016 as Director of the Adult Non-Malignant